دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Antithrombotic treatment: how to navigate between the Scylla of thrombosis and the Charybdis of bleeding?
Filippo Crea
doi : 10.1093/eurheartj/ehac535
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3499–3502
EACVI women in cardiovascular imaging: why now?Â
Julia Grapsa, Giulia Elena Mandoli, Ana G Almeida, Bernard Cosyns
doi : 10.1093/eurheartj/ehac365
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3503–3504
New opportunities on offer to aspiring interventionalistsÂ
Judith Ozkan
doi : 10.1093/eurheartj/ehac455
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3505–3507
Prof. Dr em. Dr h.c. Berndt LüderitzÂ
Gerhard Steinbeck, Thorsten Lewalter, Daniel Steven
doi : 10.1093/eurheartj/ehac433
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3508–3509
Coronary artery calcium scoring for cardiovascular risk stratification: more pitfalls than advantages?
Rocco Vergallo, Giovanna Liuzzo
doi : 10.1093/eurheartj/ehac443
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3510–3511
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 weekÂ
Raffaele De Caterina, Stefan Agewall, Felicita Andreotti, Dominick J Angiolillo, Deepak L Bhatt, Robert A Byrne, Jean-Philippe Collet, John Eikelboom, Alexander C Fanaroff, C Michael Gibson, Andreas Goette, Gerhard Hindricks, Gregory Y H Lip, Tatjana Potpara, Holger Thiele, Renato D Lopes, Mattia Galli
doi : 10.1093/eurheartj/ehac294
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3512–3527
Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational studyÂ
Joris J Komen, Anton Pottegård, Aukje K Mantel-Teeuwisse, Tomas Forslund, Paul Hjemdahl, Björn Wettermark, Jesper Hallas, Morten Olesen, Marion Bennie, Tanja Mueller, Raymond Carragher, Øystein Karlstad, Lars J Kjerpeseth, Olaf H Klungel
doi : 10.1093/eurheartj/ehac111
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3528–3538
There is currently no consensus on whether atrial fibrillation (AF) patients at low risk for stroke (one non-sex-related CHA2DS2-VASc point) should be treated with an oral anticoagulant.
Atrial fibrillation and stroke: who is low risk and what are we going to do about it?Â
William F McIntyre, Dominik Linz
doi : 10.1093/eurheartj/ehac099
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3539–3541
Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial
Masatsugu Hori, Jun Zhu, Yan Liang, Deepak L Bhatt, Jackie Bosch, Stuart J Connolly, Keith A A Fox, Aldo Maggioni, Salim Yusuf, John W Eikelboom
doi : 10.1093/eurheartj/ehac309
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3542–3552
It is unknown whether Asian and non-Asian patients with atherosclerotic vascular disease derive similar benefits from long-term antithrombotic therapy.
Potent antithrombotic treatments in Asian vs. non-Asian patientsÂ
Shinya Goto, Shinichi Goto
doi : 10.1093/eurheartj/ehac390
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3553–3555
Galectin 3 enhances platelet aggregation and thrombosis via Dectin-1 activation: a translational studyÂ
Yufei Chen, Wanrong Fu, Yunbo Zheng, Jing Yang, Yangyang Liu, Zhiyong Qi, Meiling Wu, Zhichao Fan, Kanhua Yin, Yunfeng Chen, Wen Gao, Zhongren Ding, Jianzeng Dong, Qi Li, Si Zhang, Liang Hu
doi : 10.1093/eurheartj/ehac034
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3556–3574
Galectin-3, a β-galactoside-binding lectin, is abnormally increased in cardiovascular disease. Plasma Galectin-3 receives a Class II recommendation for heart failure management and has been extensively studied for multiple cellular functions.
Galectin-3 inhibitors as novel antithrombotic drugs with almost no bleeding risk: wishful thinking or a realistic vision?Â
Kai Jakobs, Ursula Rauch
doi : 10.1093/eurheartj/ehac128
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3575–3577
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
Dipak Kotecha, Folkert W Asselbergs, Stephan Achenbach, Stefan D Anker, Dan Atar, Colin Baigent, Amitava Banerjee, Birgit Beger, Gunnar Brobert, Barbara Casadei, Cinzia Ceccarelli, Martin R Cowie, Filippo Crea, Maureen Cronin, Spiros Denaxas, Andrea Derix, Donna Fitzsimons, Martin Fredriksson, Chris P Gale, Georgios V Gkoutos, Wim Goettsch, Harry Hemingway, Martin Ingvar, Adrian Jonas, Robert Kazmierski, Susanne Løgstrup, R Thomas Lumbers, Thomas F Lüscher, Paul McGreavy, Ileana L Piña, Lothar Roessig, Carl Steinbeisser, Mats Sundgren, Benoît Tyl, Ghislaine van Thiel, Kees van Bochove, Panos E Vardas, Tiago Villanueva, Marilena Vrana, Wim Weber, Franz Weidinger, Stephan Windecker, Angela Wood, Diederick E Grobbee, the Innovative Medicines Initiative BigData@Heart Consortium, European Society of Cardiology, CODE-EHR international consensus group
doi : 10.1093/eurheartj/ehac426
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3578–3588
Big data is central to new developments in global clinical science aiming to improve the lives of patients. Technological advances have led to the routine use of structured electronic healthcare records with the potential to address key gaps in clinical evidence. The covid-19 pandemic has demonstrated the potential of big data and related analytics, but also important pitfalls.
Challenges of diversity and inclusion and the need for changeÂ
Estefania Oliveros, Stephen McHugh, Daniel Brito, Clyde Yancy
doi : 10.1093/eurheartj/ehac011
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3589–3592,
Recurrent pulmonary thrombosis after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
Tomohiko C Umei, Yoshikazu Kishino, Takashi Kawakami, Keiichi Fukuda
doi : 10.1093/eurheartj/ehac419
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Page 3593
Transcatheter mitral valve implantation in severely calcified rheumatic mitral stenosis without annular calcification
Zhen Gang Zhao, Fei Chen, Xin Wei, Yuan Feng, Mao Chen
doi : 10.1093/eurheartj/ehac421
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Page 3594
